Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Cetuximab-loaded self-assembled polymeric nanoparticles for the integrin-targeted therapy of glioblastoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
10.1056/nejmoa043330 · 2005 · External reference
The 2021 WHO classification of tumors of the central nervous system: a summary
10.1093/neuonc/noab106 · 2021 · External reference
Diagnosis and management of glioblastoma: a comprehensive perspective
10.3390/jpm11040258 · 2021 · External reference
Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma
10.1016/j.ijrobp.2011.06.1992 · 2012 · External reference
Nordic clinical brain tumour study group (NCBTSG), temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the nordic randomised, phase 3 trial
10.1016/s1470-2045(12)70265-6 · 2012 · External reference
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol
10.1186/s12885-019-5413-y · 2019 · External reference
MGMT gene silencing and benefit from temozolomide in glioblastoma
10.1056/nejmoa043331 · 2005 · External reference
Emerging treatment strategies for glioblastoma multiforme
10.15252/emmm.201302627 · 2014 · External reference
Management of glioblastoma: state of the art and future directions
2020 · External reference
Breaking barriers for glioblastoma with a path to enhanced drug delivery
10.1038/s41467-023-41694-9 · 2023 · External reference
Advances in glioblastoma therapy: an update on current approaches
10.3390/brainsci13111536 · 2023 · External reference
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
10.1038/s41571-020-00447-z · 2021 · External reference
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
10.1038/s41388-017-0045-7 · 2018 · External reference
Targeting angiogenesis in gliomas: potential role of phytochemicals
10.1016/j.jff.2022.105192 · 2022 · External reference
The promise of DNA damage response inhibitors for the treatment of glioblastoma, neuro-oncol
2021 · External reference
How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme
10.1007/s43440-021-00349-6 · 2022 · External reference
A novel approach to glioblastoma multiforme treatment using modulation of key pathways by naturally occurring small molecules
10.1007/s10787-025-01666-5 · 2025 · External reference
Defining the role of mTOR in cancer
10.1016/j.ccr.2007.05.008 · 2007 · External reference
Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance
2010 · External reference
Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation
10.1073/pnas.83.11.3825 · 1986 · External reference
Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximab
10.4161/cbt.24342 · 2013 · External reference
Cetuximab-conjugated magnetic poly(Lactic-co-glycolic acid) nanoparticles for dual-targeted delivery of Irinotecan in glioma treatment
10.3390/ma16165526 · 2023 · External reference
The blood-brain barrier: structure, regulation, and drug delivery
10.1038/s41392-023-01481-w · 2023 · External reference
Microphysiological systems for recapitulating physiology and function of blood-brain barrier
10.1016/j.biomaterials.2019.119732 · 2020 · External reference
Lipid based nanoparticles: current strategies for brain tumor targeting
10.2174/2405461504666190510121911 · 2019 · External reference
Strategies facilitating the permeation of nanoparticles through blood-brain barrier: an insight towards the development of brain-targeted drug delivery system
2023 · External reference
Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier
10.1016/j.actbio.2025.02.065 · 2025 · External reference
Strategies for delivering therapeutics across the blood-brain barrier
10.1038/s41573-021-00139-y · 2021 · External reference
The blood-brain barrier: physiology and strategies for drug delivery
10.1016/j.addr.2019.11.009 · 2020 · External reference
Nanoparticles mediated the diagnosis and therapy of glioblastoma: bypass or cross the blood-brain barrier
2023 · External reference
Functionalized nanoparticles crossing the brain–blood barrier to target glioma cells
10.7717/peerj.15571 · 2023 · External reference
RGD-based self-assembling nanodrugs for improved tumor therapy
2024 · External reference
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
10.1186/s12943-023-01865-0 · 2023 · External reference
Engineering precision nanoparticles for drug delivery
10.1038/s41573-020-0090-8 · 2021 · External reference
Functionalized nanomaterials capable of crossing the blood–brain barrier
10.1021/acsnano.3c10674 · 2024 · External reference
Emerging blood–brain- barrier-crossing nanotechnology for brain cancer theranostics
10.1039/c8cs00805a · 2019 · External reference
Nanoparticle diagnostics and theranostics in the clinic
2022 · External reference
All-aqueous electrosprayed emulsion for templated fabrication of cytocompatible microcapsules
10.1021/acsami.5b02708 · 2015 · External reference
Microfluidic generation of aqueous two-phase-system (ATPS) droplets by oil-droplet choppers
10.1039/c7lc00696a · 2017 · External reference
Advances in nanoparticle synthesis assisted by microfluidics
10.1039/d5lc00194c · 2025 · External reference
Chitosan-based colloidal polyelectrolyte complexes for drug delivery: a review
10.1016/j.carbpol.2020.116126 · 2020 · External reference
Ternary polysaccharide complexes: colloidal drug delivery systems stabilized in physiological media
10.1016/j.carbpol.2017.05.051 · 2017 · External reference
Polyelectrolyte complexes: a review of their applicability in drug delivery technology
10.4103/0250-474x.58165 · 2009 · External reference
Polyelectrolyte complex coacervates: structural insights, rheological perspectives, and industrial applications
10.1007/s12221-025-00975-4 · 2025 · External reference
Amphiphilic polymeric nanoparticles modified with a retro-enantio peptide shuttle target the brain of mice
10.1021/acs.chemmater.0c01696 · 2020 · External reference
Amphiphilic polymeric nanoparticles modified with a protease-resistant peptide shuttle for the delivery of SN-38 in diffuse intrinsic pontine glioma
10.1021/acsanm.0c02888 · 2021 · External reference
Doubly self-assembled dermatan sulfate/chitosan nanoparticles for targeted siRNA delivery in cancer therapy
10.1016/j.jcis.2024.11.132 · 2025 · External reference
Effect of poly(ethylene glycol) (PEG) spacers on the conformational properties of small peptides: a molecular dynamics study
10.1021/la103800h · 2011 · External reference
Excipient-free pure drug nanoparticles fabricated by microfluidic hydrodynamic focusing
10.3390/pharmaceutics13040529 · 2021 · External reference
How to determine entrapment efficiency in lipid and polymeric nanoparticles: a methodological guide
2026 · External reference
DDSolver: an Add-In program for modeling and comparison of drug dissolution profiles
10.1208/s12248-010-9185-1 · 2010 · External reference
Applications of chitosan-alginate-based nanoparticles—an up-to-date review
10.3390/nano12020186 · 2022 · External reference
Antibiotic-loaded amphiphilic chitosan nanoparticles target macrophages and kill an intracellular pathogen
10.1002/smll.202201853 · 2022 · External reference
Interpretation of infrared spectra: a practical and systematic approach
2025 · External reference
Unresolved reference
External reference
Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results
10.1039/d3mh00717k · 2023 · External reference
Modeling and comparison of dissolution profiles
10.1016/s0928-0987(01)00095-1 · 2001 · External reference
Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier
10.1016/j.jneumeth.2012.10.001 · 2013 · External reference
Unresolved reference
External reference
Human endothelial cell interactions with surface-coupled adhesion peptides on a nonadhesive glass substrate and two polymeric biomaterials
10.1002/jbm.820250209 · 1991 · External reference
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
10.1016/s0142-9612(03)00343-0 · 2003 · External reference
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
10.1038/309030a0 · 1984 · External reference
The hCMEC/D3 cell line as a model of the human blood brain barrier
10.1186/2045-8118-10-16 · 2013 · External reference
Application of in vitro transcytosis models to brain targeted biologics
10.1371/journal.pone.0289970 · 2023 · External reference
Stapled RGD peptide enables glioma-targeted drug delivery by overcoming multiple barriers
10.1021/acsami.7b03682 · 2017 · External reference
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles
2012 · External reference
Cellular density effect on RGD ligand internalization in glioblastoma for MRI application
10.1371/journal.pone.0082777 · 2013 · External reference
EGFR-based targeted therapy for colorectal cancer—promises and challenges
10.3390/vaccines10040499 · 2022 · External reference
Integrin-αvβ3 as a therapeutic target in glioblastoma: back to the future?
10.3390/pharmaceutics14051053 · 2022 · External reference
EGF receptor-targeted nanocarriers for enhanced cancer treatment
2012 · External reference
In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab
10.1016/j.ijrobp.2007.03.002 · 2007 · External reference
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
10.1016/j.ccr.2005.03.003 · 2005 · External reference
Microfluidic-assisted preparation of RGD-decorated nanoparticles: exploring integrin-facilitated uptake in cancer cell lines
10.1038/s41598-020-71396-x · 2020 · External reference
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis
10.1073/pnas.1006507107 · 2010 · External reference
Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles
10.1038/srep07490 · 2014 · External reference
Establishment and validation of a new Co-Culture for the evaluation of the permeability through the blood–brain barrier in patients with glioblastoma
10.3390/pharmaceutics15051431 · 2023 · External reference
Quantitative analysis of nanoparticle transport through in vitro blood-brain barrier models
2016 · External reference
Influence of glioma cells on a new co-culture in vitro blood–brain barrier model for characterization and validation of permeability
10.1016/j.ijpharm.2015.05.027 · 2015 · External reference
